Description of Research: Sandro Cinti
Dr. Cinti is an infectious diseases physician with
ongoing involvement in the preparation for bioterrorism
and emerging infections at the national, state and
local level. He has been a member of the State of
Michigan Bioterrorism Subcommittee since its inception
in 1999 and is an external reviewer for the Communicable
Diseases Plan being developed by the Michigan Department
of Community Health. Dr. Cinti is also a member of
the Washtenaw County Bioterrorism Subcommittee and
the Michigan Infectious Diseases Society Bioterrorism
Subcommittee (MIDS). Both of these committees comprise
experts from many different disciplines (public health,
fire, police, HAZMAT). Dr. Cinti is also a member
of the University of Michigan Disaster Committee that
developed a hospital-wide plan for responding to a
bioterrorism event. Currently, Dr. Cinti is co-chairman
of the Region 2 South Communicable Diseases Planning
Team (formerly the Smallpox Response Planning Team)
and a member of the Region 2 South Advisory Committee.
Dr. Cinti is the Director of the Michigan Biodefense
Alert Listserv (MBAL) which was initially created
with a grant from the Michigan Department of Community
Health (MDCH). MBAL, now located at the Michigan State
Medical Society, is a clinician network that serves
as a conduit of information on bioterrorism and emerging
infections as well as a biosurveillance tool. Dr.
Cinti disseminates postings over the listserv on topics
relevant to the care of patients exposed to biological
agents or emerging infections (SARS, WNV).
At the national level, Dr. Cinti sits on the Board
of Directors of the National Center for Critical Incident
Analysis (NCCIA). This group convenes a yearly session
involving national experts in public health, medicine,
public policy, the media, and law enforcement. These
sessions explore ways that diverse groups can better
respond to critical incidents. NCCIA has developed
a model to explore critical incidents in a more systematic
manner. This model will be published in the next year.
Dr. Cinti has experience in teaching and training
groups to respond to bioterrorism. He has developed
a one week course (Epidemiology 776) that is offered
at the Summer Epidemiology Program at the University
of Michigan. He has developed a similar course for
the yearly Michigan State Medical Society (MSMS) meeting.
Also, Dr. Cinti teaches yearly bioterrorism classes
to 1st and 2nd year medical and dental students. Dr
Cinti has convened several bioterrorism response panels
for environmental journalist conferences in New Orleans,
LA and Lansing, MI.
Dr. Cinti also participates in HIV/AIDS clinical
research. He is site PI of a tri-national study involving
the VA Medical system that is looking at structured
treatment interruptions and mega-HAART regimens. He
has published on the topic of adherence to antiretroviral
regimens and recently completed a pilot study looking
at automated telephone calls as a way of improving
adherence to HIV antiretrovirals. Dr. Cinti is a member
of the UM HIV/AIDS clinical team and he is the clinical
lead of the HIV/AIDS clinic at the Ann Arbor VA which
cares for 150 HIV patients.
Cinti, SK; Gandhi, T; Riddell, J. Non-AIDS-defining
cancers: Should antiretroviral therapy be initiated
earlier? AIDS Read 18 (1): 18, 2008.
Nicolasora N, Cinti SK, Riddell J, Kauffman CA. A
53-year-old man with a large air bubble in his chest.
Diagnosis: Bronchopleural fistula and hydropneumothorax
caused by coccidioidomycosis (Photo Quiz). Clin Infect
Dis 47 (6): 823-824, 2008.
Cinti SK, Wilkerson W, Holmes JG, Shlafer J, Kim
C, Collins CD, Bandy K, Krupansky F, Lozon M, Bradin
SA, Wright C, Goldberg J, Wagner D, Rodgers P, Atas
J, Cadwallender B. Pandemic Influenza and Acute Care
Centers: Taking Care of Sick Patients in a Nonhospital
Setting. Biosecurity Bioterrorism-Biodefense Strategy
Practice Science 6 (4): 335-348, 2008.
Damuth E, Heidelbaugh J, Malani PN, Cinti SK. An
Elderly Patient with Fluoroquinolone-Associated Achilles
Tendinitis. Amer J Geriatr Pharmacother 6 (5): 264-268,
Chaiyachati K, Cinti SK, Kauffman CA, Riddell J.
HIV-Infected patients with anal carcinoma who subsequently
developed oral squamous cell carcinoma: Report of
2 cases. J Intl Ass Phys AIDS Care 7:306-11, 2008.
Cinti SK, Barnosky AR, Gay SE, Goold SD, Lozon MM,
Kim K, Rodgers PE, Baum NM, Cadwallender BA, Collins
CD, Wright CM, Winfield RA. Bacterial Pneumonias during
an influenza pandemic: How will we allocate antibiotics?
Biosec Bioterr-Biodefense Strat Pract Sci 7 (3): 311-316,
Agarwal PP, Cinti S, Kazerooni EA. Chest Radiographic
and CT Findings in Novel Swine-Origin Influenza A
(H1N1) Virus (S-OIV) Infection. Am J Roentgenol 193
(6): 1488-1493, 2009.
Kim CS, Pile JC, Lozon MM, Wilkerson WM, Wright CM,
Cinti S. Role of Hospitalists in an Offsite Alternate
Care Center (ACC) for Pandemic Flu. J Hosp Med 4 (9):
Napolitano LM, Park PK, Sihler KC, Papadimos T, Chenoweth
C, Cinti S, Zalewski C, Sharangpani R, Somsel P, Wells
E, Fry AM, Fiore AE, Lindstrom S, Uyeki TM. Intensive-care
patients with severe novel influenza (H1N1) virus
infection –Michigan, June 2009. MMWR 58;749-52.
Cinti S. Chikungunya fever: An emerging infection.
Infect Dis Clin Practice. 2009;17:6-11.
Cinti S. "Medical marijuana in HIV+ patients:
What do we do now?". J Intl Ass Phys AIDS Care.
Nichani S, Cinti S, Barsuk JH. "Making a List and Checking It Twice". J Hosp Med 6 (4): 233-237, 2011.
Cinti S, Haas K, Paliani P, Newton D, Wright C, Zalewski C, Holmes JG, Dwyer S, Friedman C, Chenoweth C. Efficacy of Surveillance for 2009 H1N1 Pandemic within a Healthcare System. Infect Contr Hosp Epidemiol 32 (8): 811-814, 2011.